Clinical Trials on Progressive Multiple Sclerosis (PMS) in Korea, Republic of
Total 205 results
-
BayerCompletedRelapsing Remitting MS (RRMS) | Secondary Progressive MS (SPMS)France, Germany, Korea, Republic of, Saudi Arabia, Spain, Taiwan, Czech Republic, Italy, Jordan, Lebanon, Turkey, Israel, Portugal, Netherlands, Iran, Islamic Republic of
-
SanofiRecruitingRelapsing Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisChina, Turkey, Korea, Republic of, United States, Ukraine
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis | Mesenchymal Stem Cells | Secondary-Progressive Multiple SclerosisIran, Islamic Republic of
-
Isfahan University of Medical SciencesCompletedSecondary Progressive Multiple SclerosisIran, Islamic Republic of
-
Mapi Pharma Ltd.Active, not recruitingPrimary Progressive Multiple SclerosisIsrael, Moldova, Republic of
-
Sina Hospital, IranCompletedMS (Multiple Sclerosis)Iran, Islamic Republic of
-
BayerWithdrawnMultiple Sclerosis, Relapsing-RemittingKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyMerck Serono Middle East FZ LLCCompletedRelapsing Multiple Sclerosis (RMS)Bulgaria, Poland, Argentina, Hungary, Korea, Republic of, Saudi Arabia, Egypt, Algeria, Bahrain, Iran, Islamic Republic of, Kuwait, Lebanon, Morocco
-
VA Office of Research and DevelopmentActive, not recruitingMultiple SclerosisUnited States, Canada
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
BayerCompletedMultiple Sclerosis | Clinically Isolated SystemKorea, Republic of
-
CinnagenCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Iran, Islamic Republic of
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
Isfahan University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Novartis PharmaceuticalsTerminatedPrimary Progressive Multiple SclerosisUnited States, Belgium, Poland, Germany, Hungary, Turkey, Spain, Australia, Canada, Czechia, Switzerland, United Kingdom, Netherlands, France, Italy, Denmark, Finland, Sweden
-
Tehran University of Medical SciencesUnknownRelapsing Remitting Multiple SclerosisIran, Islamic Republic of
-
Eisai Korea Inc.CompletedMultiple Sclerosis, Relapsing-remittingKorea, Republic of
-
Merck KGaA, Darmstadt, GermanyCompletedMultiple SclerosisKorea, Republic of
-
BayerCompletedRelapsing Remitting Multiple Sclerosis (RRMS)China, Slovakia, France, Germany, Korea, Republic of, Saudi Arabia, Singapore, Sweden, Taiwan, Colombia, Czech Republic, Estonia, Italy, Jordan, Lebanon, Mexico, Slovenia, United Kingdom, Argentina, Bahrain, Egypt, United Arab Emirates and more
-
SanofiRecruitingPrimary Progressive Multiple SclerosisSpain, Italy, Turkey, India, Israel, Bulgaria, Mexico, Greece, Portugal, United States, Argentina, Australia, Austria, Belarus, Belgium, Canada, Chile, China, Colombia, Croatia, Czechia, Denmark, Estonia, France, Georgia, Germany, Hungary, Japan and more
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis, Primary ProgressiveUnited States, Canada, Australia, United Kingdom, Hungary, Bulgaria, Puerto Rico, Poland, Argentina, Brazil, Germany, Greece, Italy, Peru, Portugal, Russian Federation, Spain, Turkey, Ukraine, Israel, France, Switzerland, Colombia, Me... and more
-
Hoffmann-La RocheRecruitingMultiple Sclerosis, Primary ProgressiveCanada, United States, Spain, Croatia, Serbia, Portugal, France, Tunisia, Mexico, Poland, Russian Federation, Australia, Belgium, Italy, United Kingdom, Ukraine, Bulgaria, Colombia, Georgia, Germany, Romania, New Zealand, Lebanon, Aus... and more
-
Imcyse SAActive, not recruitingMultiple Sclerosis, Relapsing-RemittingMoldova, Republic of
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisBelgium, United Kingdom, Netherlands, Serbia, Poland, Slovakia, Bulgaria, Turkey, Brazil, Italy, Russian Federation, Spain, Austria, Colombia, Romania, Kuwait, Chile, Dominican Republic, Egypt, Montenegro, Panama, Paraguay, Portugal, ... and more
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis, Relapsing-RemittingIran, Islamic Republic of
-
Novartis PharmaceuticalsCompletedSecondary Progressive Multiple SclerosisChina, Germany, United States, Romania, Italy, Austria, Belgium, Czechia, Spain, Australia, Canada, France, Israel, Switzerland, Japan, Bulgaria, Netherlands, United Kingdom, Estonia, Latvia, Lithuania, Russian Federation, Turkey, Slo... and more
-
Mazandaran University of Medical SciencesEnrolling by invitationMultiple Sclerosis, Relapsing-Remitting | Magnetic Resonance Imaging | MethylprednisoloneIran, Islamic Republic of
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis (MS)United States, Lebanon, Spain, Sweden, Poland, Italy, Estonia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Korea, Republic of, Lithuania, Norway, Portugal, Romania, Russian Federation and more
-
EMD Serono Research & Development Institute, Inc.Recruiting
-
Tabriz University of Medical SciencesCompletedMultiple SclerosisIran, Islamic Republic of
-
Royan InstituteCompletedMultiple SclerosisIran, Islamic Republic of
-
Tehran University of Medical SciencesCompletedMultiple Sclerosis | Oxidative StressIran, Islamic Republic of
-
Mazandaran University of Medical SciencesUnknown
-
The National Brain Mapping Laboratory (NBML)Mohaghegh Ardabili UniversityCompletedMultiple SclerosisIran, Islamic Republic of
-
Hoffmann-La RocheActive, not recruitingMultiple Sclerosis (MS)United States
-
Shiraz University of Medical SciencesRecruitingMultiple SclerosisIran, Islamic Republic of
-
Isfahan University of Medical SciencesCompletedMultiple SclerosisIran, Islamic Republic of
-
Isfahan University of Medical SciencesCompleted
-
Arak University of Medical SciencesPardis Specialized Wellness InstituteCompletedMultiple SclerosisIran, Islamic Republic of
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisPoland, Hungary, United States, Czech Republic
-
Isfahan University of Medical SciencesCompleted
-
Polpharma Biologics S.A.CompletedRelapsing-Remitting Multiple Sclerosis (RRMS)Belarus, Ukraine, Georgia, Croatia, Moldova, Republic of, Poland, Serbia
-
Institute for Clinical ResearchUnknownRelapsing-Remitting Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisKorea, Republic of, Taiwan, Czechia, Japan, Poland
-
Isfahan University of Medical SciencesUnknownMultiple Sclerosis | Cognitive DisordersIran, Islamic Republic of
-
BiogenTerminatedMultiple Sclerosis, Relapsing-RemittingMexico, Turkey, United States, Hungary, Taiwan, Thailand, Korea, Republic of, Saudi Arabia, Malaysia, Colombia, Estonia, Jordan, Tunisia